| Primary |
| Drug Use For Unknown Indication |
30.7% |
| Growth Hormone Deficiency |
24.8% |
| Product Used For Unknown Indication |
12.3% |
| Hypopituitarism |
6.8% |
| Body Height Below Normal |
5.3% |
| Growth Retardation |
3.6% |
| Renal Failure Chronic |
3.1% |
| Turner's Syndrome |
2.3% |
| Dwarfism |
2.1% |
| Prader-willi Syndrome |
1.6% |
| Attention Deficit/hyperactivity Disorder |
1.0% |
| Hypothalamo-pituitary Disorder |
1.0% |
| Pituitary Tumour Benign |
1.0% |
| Unevaluable Event |
1.0% |
| Azotaemia |
0.6% |
| Empty Sella Syndrome |
0.6% |
| Hypothyroidism |
0.6% |
| Renal Failure |
0.6% |
| Small For Dates Baby |
0.6% |
| Craniopharyngioma |
0.4% |
|
| Scoliosis |
12.8% |
| Pneumonia |
11.6% |
| Vomiting |
10.0% |
| Convulsion |
8.8% |
| Weight Increased |
7.6% |
| Intracranial Pressure Increased |
5.2% |
| Death |
4.8% |
| Urticaria |
4.8% |
| Growth Retardation |
3.6% |
| Neoplasm Recurrence |
3.6% |
| Benign Intracranial Hypertension |
3.2% |
| Diabetes Mellitus |
3.2% |
| Headache |
3.2% |
| Craniopharyngioma |
2.8% |
| Weight Decreased |
2.8% |
| Epiphysiolysis |
2.4% |
| Hospitalisation |
2.4% |
| Hypertension |
2.4% |
| Pyrexia |
2.4% |
| Respiratory Distress |
2.4% |
|
| Secondary |
| Growth Hormone Deficiency |
25.1% |
| Drug Use For Unknown Indication |
16.4% |
| Product Used For Unknown Indication |
8.5% |
| Hypopituitarism |
7.9% |
| Body Height Below Normal |
6.5% |
| Dwarfism |
5.6% |
| Growth Retardation |
5.4% |
| Renal Failure Chronic |
4.2% |
| Hypothalamo-pituitary Disorder |
3.1% |
| Azotaemia |
2.3% |
| Failure To Thrive |
2.3% |
| Diabetes Insipidus |
1.7% |
| Hypothyroidism |
1.7% |
| Prader-willi Syndrome |
1.7% |
| Psychomotor Hyperactivity |
1.7% |
| Cystic Fibrosis |
1.4% |
| Empty Sella Syndrome |
1.4% |
| Crohn's Disease |
1.1% |
| Off Label Use |
1.1% |
| Foetal Growth Restriction |
0.8% |
|
| Weight Increased |
13.5% |
| Oedema Peripheral |
10.6% |
| Growth Retardation |
7.7% |
| Urinary Tract Infection |
7.7% |
| Vomiting |
6.7% |
| Craniopharyngioma |
5.8% |
| Headache |
4.8% |
| Guillain-barre Syndrome |
3.8% |
| Haemangioma |
3.8% |
| Hepatic Cirrhosis |
3.8% |
| Pneumonia |
3.8% |
| Scoliosis |
3.8% |
| Tongue Disorder |
3.8% |
| Urticaria |
3.8% |
| Convulsion |
2.9% |
| Death |
2.9% |
| Walking Disability |
2.9% |
| Weight Decreased |
2.9% |
| Weight Gain Poor |
2.9% |
| Accidental Overdose |
1.9% |
|
| Concomitant |
| Bronchial Hyperreactivity |
11.4% |
| Type 2 Diabetes Mellitus |
11.4% |
| Convulsion |
8.6% |
| Asthma |
5.7% |
| Cor Pulmonale Chronic |
5.7% |
| Gastrooesophageal Reflux Disease |
5.7% |
| Hypertension |
5.7% |
| Hypopituitarism |
5.7% |
| Peritoneal Dialysis |
5.7% |
| Vesicoureteric Reflux |
5.7% |
| Arthritis |
2.9% |
| Blood Cholesterol Increased |
2.9% |
| Blood Growth Hormone |
2.9% |
| Blood Pressure |
2.9% |
| Bronchopneumonia |
2.9% |
| Dysphagia |
2.9% |
| Hypothyroidism |
2.9% |
| Incontinence |
2.9% |
| Irritable Bowel Syndrome |
2.9% |
| Multiple Allergies |
2.9% |
|
| Pancreatitis |
25.0% |
| Bronchospasm |
12.5% |
| Dizziness |
12.5% |
| Injection Site Haematoma |
12.5% |
| Injection Site Pain |
12.5% |
| Streptococcal Infection |
12.5% |
| Vomiting |
12.5% |
|
